"Preclinical" MSA in definite Creutzfeldt-Jakob disease

Neuropathology

Volumn 32, Issue 2, 2012, Pages 158-163

  Rodriguez Diehl, Roberta ^a,g   Rey, Maria Jesus ^a   Gironell, Alexandre ^b   Martinez Saez, Elena ^c   Ferrer, Isidre ^d   Sánchez Valle, Raquel ^e   Jagüe, Jordi ^e   Nos, Carlos ^f   Gelpi, Ellen ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e Hospital Clinic   (Spain)

^f General Subdirectorate of Surveillance and Response to Emergencies in Public Health   (Spain)

^g Santa Casa Complexo Hospitalar   (Brazil)

Author keywords

Alpha synuclein; Creutzfeldt Jakob disease; Minimal change MSA; Preclinical MSA; Prion protein

Indexed keywords

ALPHA SYNUCLEIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ADULT; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CASE REPORT; CELL INCLUSION; CEREBELLAR ATAXIA; CORPUS STRIATUM; CREUTZFELDT JAKOB DISEASE; DEATH; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PRIORITY JOURNAL; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA; WALKING SPEED;

CREUTZFELDT-JAKOB SYNDROME; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY;

EID: 84859001102     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2011.01232.x     Document Type: Article

References (13)

1. Wenning GK, Ben- Shlomo Y, Magalhães M, Daniel SE, Quinn NP. Clinopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995; 58: 160-166.
2. Wakabayashi K, Takahashi H. Cellular pathology in multiple system atrophy. Neuropathology 2006; 26: 338-345.
3. Parkkinen L, Hartikainen P, Alafuzoff I. Abundant glial alpha- synuclein pathology in a case without overt clinical symptoms. Clin Neuropathol 2007; 26: 276-283.
4. Wenning GK, Jellinger KA. The role of alpha- synuclein in the pathogenesis of multiple system atrophy. Acta Neuropathol 2005; 109: 129-140.
5. Fujishiro H, Ahn TB, Frigerio R etal. Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy. Acta Neuropathol 2008; 116: 269-275.
6. Zerr I, Kallenberg K, Summers DM etal. Update clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009; 132: 2659-2668.
7. Trojanowski JQ, Revesz T. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 2007; 33: 615-620.
8. Jellinger KA, Seppi K, Wenning GK. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 2005; 20 (Suppl 12): S29-S36.
9. Wakabayashi K, Mori F, Nishie M etal. An autopsy case of early ("minimal change") olivopontocerebellar atrophy (multiple system atrophy cerebellar). Acta Neuropathol 2005; 110: 185-190.
10. Uchikado H, Delledonne A, Uitti R, Dickson DW. Coexistence of PSP and MSA: a case report and review of the literature. Acta Neuropathol 2006; 111: 186-192.
11. Clinton LK, Blurton- Jones M, Myczek K, Trojanowski JQ, Laferla FM. Synergistic interactions between Aβ, Tau and α- Synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 2010; 30: 7281-7289.
12. Kovacs GG, Seguin J, Quadrio I. Genetic Creutzfeldt- Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy. Acta Neuropathol 2011; 121: 39-57.
13. Shibao C, Garland EM, Gamboa A. PRNP M129V homozygosity in multiple system atrophy vs. Parkinson's disease. Clin Auton Res 2008; 18: 13-19.